Victoria Socha

DocwireNews

Implementing individualized treatment 
in the era of precision medicine calls for examining sex-specific data. 
Previous studies have established the importance of sexual dimorphisms for 
hypertension and cardiovascular complications regarding disease presentation, 
likelihood of disease progression, and response to treatment. There are few 
data available on the impact of sex on chronic kidney disease (CKD); the 
mechanisms underlying the observed sex disparity in the epidemiology of kidney 
diseases.Researchers in Italy, led by Roberto 
Minutolo, MD, PhD, recently conducted a pooled analysis of four Italian 
observational cohort studies to examine the association between sex and CKD. 
Results of the analysis were reported in the American Journal of Kidney 
Diseases [2020;75(1):30-38].The researchers sought to evaluate 
the potential effect of sex on CKD progression in analyses of data on men and 
women with moderate to advanced CKD in a multicohort study group regularly 
followed up in renal clinics in Italy. The four studies in the analysis were 
conducted in 40 nephrology clinics in Italy. The primary aim of the four 
studies differed but they shared similar inclusion and exclusion criteria. Each 
cohort enrolled consecutive patients with CKD under stable nephrology care for 
at least 6 months. In all four cohorts, participating 
nephrologists collected demographic information and clinical history. Physical 
examinations were performed, including assessment of height, body weight, blood 
pressure, and medication profile. Data were collected in anonymous electronic 
case reports and subsequently sent to the coordinating centers for quality 
assessment, storage, and analyses.For the current analysis, the primary 
outcome of interest was time to end-stage renal disease (ESRD), defined as 
maintenance dialysis or kidney transplantation. For time to ESRD, death before 
ESRD was a competing event. Secondary end points included time to all-cause 
mortality and the slope of change in estimated glomerular filtration rate 
(eGFR).The initial pooled cohorts included 
3212 individuals. Of those 148 were duplicate patients, 13 had missing 
information, and 716 had eGFR &gt;45 mL/min/1.73 m2, resulting in an 
analysis cohort of 2335 individuals (1311 men and 1024 women). In the four 
cohorts, sex distribution as similar. There were no differences in age and the 
prevalence of diabetes between men and women; the prevalence of smokers, left 
ventricular hypertrophy, and history of cardiovascular disease was higher in 
men than in women. On average, eGFR was 1.6 mL/min/1.73 
m2 lower in women, and women had a different prevalence of CKD 
stage. Mean eGFR was similar in men and women in stage 3B and stage 4 CKD; it 
was slightly higher in women in stage 5 CKD. Proteinuria was higher in men 
compared with women: 56.3% of men and 46.2% of women had protein excretion 
&gt;0.5 g/d (P&lt;.001).Blood pressures were similar in men 
and women; achievement of blood pressure &lt;130/80 mm Hg was also similar 
between the two groups. In terms of number of antihypertensive drugs and use of 
renin-angiotensin system inhibitors, calcium channel blockers, and 
beta-blockers, the two groups were similar; women used diuretics more 
frequently compared with men. Prescription of statins and antiplatelet drugs 
was similar between the two groups; women received erythropoiesis-stimulating 
agents more frequently than men (20.8% vs 15.0%; P&lt;.001). Women 
adhered more frequently to nonpharmacological recommendations for CKD; 
intensity of nephrology care was similar between the groups.During a median follow-up of 4.21 
years, there were 727 ESRD events (295 in women and 432 in men); the overall 
incidence rate was 7.92 per 10 person-years (7.19/100 person-years in women and 
8.53/100 person-years in men. When taking into account the competing risk for 
death prior to development of ESRD, the analysis of cumulative incidence of 
ESRD was higher in men overall and by CKD stage subgroup. In the entire cohort, 
the adjusted risk for ESRD was 50% greater in men than in women. The higher 
risk for men persisted across CKD stages (range, 52% in stage 3b to 41% in 
stage 5).Results of multivariable survival 
analysis demonstrated a significant interaction between sex and proteinuria (P=.02) 
in predicting risk of ESRD. The relative risk for ESRD for men versus women was 
dependent on proteinuria levels, with the rate becoming significantly greater 
in men at protein excretion of ~0.5 g/d or greater. The results suggested that 
a male patient with CKD with protein excretion of 1 g/d has a 50% higher risk 
for progressing to ESRD than a female patient with the same level of 
proteinuria.In secondary outcome analysis, 471 
patients died during follow-up (196 women and 275 men); the incidence rate was 
similar in the two groups (4.77/100 person-years in women and 5.43/100 
person-years in men). In the entire cohort, the adjusted risk for death was 
higher in men than in women; the difference was not statistically significant 
but was consistent across CKD stage.Decline in eGFR over time was 
assessed in patients who had at least one eGFR post-baseline assessment: 98.2% 
of the cohort (n=2292). In mixed-regression analysis, there was a significant 
difference in eGFR reduction between men and women. Adjusted eGFR change was 
&ndash;1.79 mL/min/1.73 m2 in women and &ndash;2.09 mL/min/1.73 m2 in 
men. Sex differences in the rate of eGFR decline were not different across CKD 
stages.There were some limitations to the 
analysis cited by the authors, including the relatively large sample size in 
the context of the study setting; persistence of results following 
stratification for the four cohorts; and simultaneous evaluation of ESRD and 
mortality.The researchers said, &ldquo;In conclusion, 
in elderly patients with moderate to advanced CKD under nephrology care, the 
risk for progression to ESRD is 50% higher in men than in women, irrespective 
of CKD stage, and men experience a steeper eGFR decline compared with women. 
Proteinuria levels may modify the association between sex and renal risk.&rdquo;Takeaway Points<ol class="wp-block-list">
<li>Researchers in Italy conducted a 
pooled analysis from four cohort studies to examine the association between sex 
and progression of chronic kidney disease (CKD); the cohorts included elderly 
patients treated at nephrology clinics in Italy.</li>
<li>The primary outcome of interest was 
end-stage renal disease (ESRD) (defined as requiring maintenance dialysis or 
kidney transplant); secondary outcomes were all-cause mortality and decline in 
estimated glomerular filtration rate.</li>
<li>The adjusted risks for ESRD and 
mortality were higher in men; the finding was consistent across stages of CKD.</li>
</ol>

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Latest News

Sex Differences in CKD Progression

Chronic Kidney Disease

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe